Generation Bio Co.: Nasdaq/NYSE listing notice — Generation Bio receives Nasdaq bid-price deficiency notice; must regain compliance by Aug 25, 2025

Generation Bio Co.

Closing bid price below $1.00 for 30 consecutive business days triggered Nasdaq notice.
Company has 180 days, until August 25, 2025, to regain compliance.
To comply, closing bid must be at least $1.00 for 10 consecutive business days.
If not compliant by deadline, may transfer to Nasdaq Capital Market for 180-day extension.
Possible options include reverse stock split; delisting risk persists.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Generation Bio Co. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

February 24, 2025, Generation Bio Co. (the “Company”) received written notification (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market, pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s com

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001558370-25-001950

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.